Property, Plant and Equipment, Gross of TEVA PHARMACEUTICAL INDUSTRIES LTD from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Summary
TEVA PHARMACEUTICAL INDUSTRIES LTD quarterly Property, Plant and Equipment, Gross in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD Property, Plant and Equipment, Gross for the quarter ending 31 Dec 2025 was $8,807,000,000, a 2% decline year-over-year.
Source SEC data
View on sec.gov
Property, Plant and Equipment, Gross, Quarterly (USD)
Property, Plant and Equipment, Gross, YoY Quarterly Change (%)

TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Property, Plant and Equipment, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $8,807,000,000 -$184,000,000 -2% 31 Dec 2025 10-K 03 Feb 2026 2025 FY
Q4 2024 $8,991,000,000 -$2,396,000,000 -21% 31 Dec 2024 10-K 03 Feb 2026 2025 FY
Q4 2023 $11,387,000,000 +$130,000,000 +1.2% 31 Dec 2023 10-K 05 Feb 2025 2024 FY
Q4 2022 $11,257,000,000 +$34,000,000 +0.3% 31 Dec 2022 10-K 12 Feb 2024 2023 FY
Q4 2021 $11,223,000,000 -$165,000,000 -1.4% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q4 2020 $11,388,000,000 +$38,000,000 +0.34% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q4 2019 $11,350,000,000 -$446,000,000 -3.8% 31 Dec 2019 10-K 10 Feb 2021 2020 FY
Q3 2019 $11,816,000,000 -$160,000,000 -1.3% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $11,830,000,000 -$131,000,000 -1.1% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $11,826,000,000 -$268,000,000 -2.2% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $11,796,000,000 -$382,000,000 -3.1% 31 Dec 2018 10-K 21 Feb 2020 2019 FY
Q3 2018 $11,976,000,000 -$400,000,000 -3.2% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 $11,961,000,000 -$285,000,000 -2.3% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $12,094,000,000 -$51,000,000 -0.42% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 $12,178,000,000 +$252,000,000 +2.1% 31 Dec 2017 10-K 19 Feb 2019 2018 FY
Q3 2017 $12,376,000,000 +$134,000,000 +1.1% 30 Sep 2017 6-K 02 Nov 2017 2017 Q3
Q2 2017 $12,246,000,000 30 Jun 2017 6-K 03 Aug 2017 2017 Q2
Q1 2017 $12,145,000,000 31 Mar 2017 6-K 11 May 2017 2017 Q1
Q4 2016 $11,926,000,000 +$1,853,000,000 +18% 31 Dec 2016 10-K 12 Feb 2018 2017 Q4
Q3 2016 $12,242,000,000 30 Sep 2016 6-K 15 Nov 2016 2016 Q3
Q4 2015 $10,073,000,000 +$193,000,000 +2% 31 Dec 2015 20-F 15 Feb 2017 2016 Q4
Q4 2014 $9,880,000,000 +$140,000,000 +1.4% 31 Dec 2014 20-F 11 Feb 2016 2015 Q4
Q4 2013 $9,740,000,000 +$602,000,000 +6.6% 31 Dec 2013 20-F 09 Feb 2015 2014 Q4
Q4 2012 $9,138,000,000 +$762,000,000 +9.1% 31 Dec 2012 20-F 10 Feb 2014 2013 FY
Q4 2011 $8,376,000,000 +$1,755,000,000 +27% 31 Dec 2011 20-F 12 Feb 2013 2012 FY
Q4 2010 $6,621,000,000 31 Dec 2010 20-F 17 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.